dc.contributorUniversidade Federal de Minas Gerais (UFMG)
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorFac Ciencias Med Minas Gerais
dc.creatorRocha, Fabio Lopes
dc.creatorFuzikawa, Cintia
dc.creatorRiera, Rachel [UNIFESP]
dc.creatorRamos, Melissa Guarieiro
dc.creatorHara, Claudia
dc.date.accessioned2016-01-24T14:31:08Z
dc.date.accessioned2023-09-04T18:32:21Z
dc.date.available2016-01-24T14:31:08Z
dc.date.available2023-09-04T18:32:21Z
dc.date.created2016-01-24T14:31:08Z
dc.date.issued2013-01-10
dc.identifierJournal of Affective Disorders. Amsterdam: Elsevier B.V., v. 144, n. 1-2, p. 1-6, 2013.
dc.identifier0165-0327
dc.identifierhttp://repositorio.unifesp.br/handle/11600/35875
dc.identifier10.1016/j.jad.2012.04.048
dc.identifierWOS:000311640300001
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8615899
dc.description.abstractBackground: Antidepressant combination has been suggested as a strategy to increase treatment efficacy. the objective of this study was to perform a systematic review and meta-analysis of studies that assessed the effect of antidepressant combination for major depression in patients with incomplete response to an initial antidepressant.Methods: Studies were retrieved from PubMed (1966-February, 2012), Cochrane Library (-February, 2012), Embase (1980-February, 2012), PsycINFO (1980-February, 2012), Lilacs (1982-February, 2012), clinical trials registry, thesis database (www.capes.gov.br), and secondary references. Included studies had an open label phase in which an initial antidepressant was used for the treatment of major depression and a double blind phase for the incomplete responders that compared monotherapy with the first antidepressant versus the association of a second antidepressant to the first one.Results: Out of the 4,884 studies retrieved, only five satisfied the inclusion criteria. the total number of patients included was 483. Only two small trials reported benefits of adding a second antidepressant to the initial antidepressant. Dropouts due to side effects were not reported in three studies. Meta-analysis was not performed due to the small number of studies, the inconsistency in the direction of effect and the possible instability of effect size. Only limited kinds of combination, involving mianserin, mirtazapine and desipramine were studied. Some properties of the first two drugs such as the anxiolytic, sedative, and orexigenic effects, can mimic depression improvement.Limitations: Publication bias cannot be ruled out. Only one study included a monotherapy arm with the antidepressant used for augmentation of the first antidepressant.Conclusions: the practice of using a combination of antidepressants for major depression in incomplete responders is not warranted by the literature. (C) 2012 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationJournal of Affective Disorders
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.rightsAcesso restrito
dc.subjectAntidepressant agents
dc.subjectCombination drug therapy
dc.subjectMajor depressive disorder
dc.subjectTreatment resistance
dc.titleAntidepressant combination for major depression in incomplete responders-a systematic review
dc.typeResenha


Este ítem pertenece a la siguiente institución